Seattle Times -- Seattle biotech Dendreon, fresh off winning regulatory approval for its cancer therapy, confirmed Monday it’s moving its headquarters and other local operations to a brand-new, bigger building.
Seattle Times -- Seattle biotech Dendreon, fresh off winning regulatory approval for its cancer therapy, confirmed Monday it’s moving its headquarters and other local operations to a brand-new, bigger building.
